Real-World Efficacy and Safety of Sintilimab-Based Regimens against Advanced Esophageal Cancer: A Single-Center Retrospective Observational Study

<div>Tumor response in 50 patients. (a) Best changes from baseline in measurable target lesions. (b) Longitudinal changes in measurable target lesions. CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Real-World Efficacy and Safety of Sintilimab-Based Regimens against Advanced Esophageal Cancer: A Single-Center Retrospective Observational Study 

Figure 1 | Real-World Efficacy and Safety of Sintilimab-Based Regimens against Advanced Esophageal Cancer: A Single-Center Retrospective Observational Study 